Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 2938468)

Published in Eur Heart J on August 27, 2010

Authors

Jian Yang1, Lifang Yang, Yi Wan, Jian Zuo, Jun Zhang, Wensheng Chen, Jun Li, Lijun Sun, Shiqiang Yu, Jincheng Liu, Tao Chen, Weixun Duan, Lize Xiong, Dinghua Yi

Author Affiliations

1: Xijing Cardiovascular Hospital, Fourth Military Medical University, Xi'an, China.

Associated clinical trials:

Transcatheter Closure Versus Surgery of Perimembranous Ventricular Septal Defects | NCT00890799

Articles cited by this

Transcatheter closure of ventricular septal defects. Circulation (1988) 2.05

Is complete heart block after surgical closure of ventricular septum defects still an issue? Ann Thorac Surg (2006) 2.05

Preoperative transcatheter closure of congenital muscular ventricular septal defects. N Engl J Med (1991) 2.00

Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J (2007) 1.89

Transcatheter closure of congenital ventricular septal defects in adult: mid-term results and complications. Int J Cardiol (2008) 1.64

Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. J Am Coll Cardiol (2006) 1.58

Transcatheter closure of ventricular septal defects using the Rashkind device: initial experience. Catheter Cardiovasc Interv (1999) 1.55

Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children. J Am Coll Cardiol (1999) 1.54

Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry. Catheter Cardiovasc Interv (2006) 1.53

Transcatheter closure of perimembranous ventricular septal defects in infants and children using the Amplatzer perimembranous ventricular septal defect occluder. Am J Cardiol (2007) 1.52

A comparative study: Early results and complications of percutaneous and surgical closure of ventricular septal defect. Cardiology (2009) 1.47

Comparison of results and complications of surgical and Amplatzer device closure of perimembranous ventricular septal defects. Int J Cardiol (2006) 1.45

Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: technical and morphological considerations. Catheter Cardiovasc Interv (2004) 1.40

Ventricular septal defects. Circulation (2006) 1.39

Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Catheter Cardiovasc Interv (2002) 1.39

Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. J Am Coll Cardiol (2007) 1.32

Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders. Am J Cardiol (2005) 1.28

Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: initial results and technical considerations. Catheter Cardiovasc Interv (2000) 1.27

Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation (2004) 1.11

Transcatheter closure of membranous ventricular septal defects with a new nitinol prosthesis in a natural swine model. Catheter Cardiovasc Interv (2000) 1.09

Transcatheter closure of perimembranous ventricular septal defect using a modified double-disk occluder. Am J Cardiol (2008) 1.06

Transcatheter closure of perimembranous ventricular septal defect: is the risk of heart block too high a price? Heart (2006) 1.06

Transcatheter device closure of ventricular septal defects: immediate results and intermediate-term follow-up. Am Heart J (1999) 1.03

Perforation of the right aortic valve cusp: complication of ventricular septal defect closure with a modified Rashkind umbrella. Pediatr Cardiol (1996) 1.01

Use of the Amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects. Heart (2006) 1.00

Percutaneous closure of ventricular septal defects. Cardiol Young (2007) 1.00

Percutaneous closure of congenital and acquired ventricular septal defects--considerations on selection of the occlusion device. J Interv Cardiol (2005) 0.97

Percutaneous closure of ventricular septal defects in children aged <12: early and mid-term results. Eur Heart J (2006) 0.84

Ventricular septal defect closure: what is the role for transcatheter closure? Cardiology (2009) 0.79

Articles by these authors

(truncated to the top 100)

The diploid genome sequence of an Asian individual. Nature (2008) 46.29

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell (2005) 20.30

The sequence and de novo assembly of the giant panda genome. Nature (2009) 15.76

TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature (2007) 8.87

The genome of the cucumber, Cucumis sativus L. Nat Genet (2009) 8.19

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02

An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science (2012) 7.94

The Genomes of Oryza sativa: a history of duplications. PLoS Biol (2005) 7.67

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet (2010) 7.11

Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res (2013) 6.89

Echinococcosis. Lancet (2003) 6.83

Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet (2009) 6.79

The specific and essential role of MAVS in antiviral innate immune responses. Immunity (2006) 6.74

A draft sequence for the genome of the domesticated silkworm (Bombyx mori). Science (2004) 6.62

Adaptive particle swarm optimization. IEEE Trans Syst Man Cybern B Cybern (2009) 6.47

Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A (2008) 6.42

TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell (2004) 6.00

MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell (2011) 5.91

Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell (2010) 5.83

Prestin is required for electromotility of the outer hair cell and for the cochlear amplifier. Nature (2002) 5.54

Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science (2006) 5.52

Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med (2013) 5.38

Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A (2005) 5.31

A genetic variation map for chicken with 2.8 million single-nucleotide polymorphisms. Nature (2004) 5.24

Resequencing of 31 wild and cultivated soybean genomes identifies patterns of genetic diversity and selection. Nat Genet (2010) 5.20

Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol (2006) 5.14

An Aboriginal Australian genome reveals separate human dispersals into Asia. Science (2011) 4.84

Direct activation of protein kinases by unanchored polyubiquitin chains. Nature (2009) 4.65

NLRX1 is a regulator of mitochondrial antiviral immunity. Nature (2008) 4.55

Natural malaria infection in Anopheles gambiae is regulated by a single genomic control region. Science (2006) 4.38

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. Blood (2010) 4.33

A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol (2008) 4.28

Targeted genome modification of crop plants using a CRISPR-Cas system. Nat Biotechnol (2013) 4.19

KaKs_Calculator: calculating Ka and Ks through model selection and model averaging. Genomics Proteomics Bioinformatics (2006) 4.15

[Human natural infection of Plasmodium knowlesi]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (2006) 3.99

Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature (2007) 3.91

Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol (2002) 3.89

Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet (2004) 3.83

Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68

A gate-latch-lock mechanism for hormone signalling by abscisic acid receptors. Nature (2009) 3.63

Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science (2013) 3.61

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity (2002) 3.46

T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat Immunol (2008) 3.45

The role of geography in human adaptation. PLoS Genet (2009) 3.41

Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science (2013) 3.40

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med (2008) 3.33

Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study. Acad Radiol (2005) 3.33

Respiratory morbidity in late preterm births. JAMA (2010) 3.11

Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science (2013) 3.10

Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol (2012) 3.08

A global reference for fetal-weight and birthweight percentiles. Lancet (2011) 3.05

Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs. Hepatology (2012) 3.04

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00

Mouse transcriptome: neutral evolution of 'non-coding' complementary DNAs. Nature (2004) 3.00

Prestin-based outer hair cell motility is necessary for mammalian cochlear amplification. Neuron (2008) 2.98

Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell (2013) 2.97

Macrosomia in 23 developing countries: an analysis of a multicountry, facility-based, cross-sectional survey. Lancet (2013) 2.89

Genome-wide measurement of RNA folding energies. Mol Cell (2012) 2.85

The crystal structure of mouse VDAC1 at 2.3 A resolution reveals mechanistic insights into metabolite gating. Proc Natl Acad Sci U S A (2008) 2.82

Antiviral innate immunity pathways. Cell Res (2006) 2.80

Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem (2004) 2.79

A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol (2007) 2.77

Concepts in immunology and diagnosis of hydatid disease. Clin Microbiol Rev (2003) 2.77

IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections. Hepatology (2015) 2.76

Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet (2008) 2.71

Complete resequencing of 40 genomes reveals domestication events and genes in silkworm (Bombyx). Science (2009) 2.68

Brain anatomical network and intelligence. PLoS Comput Biol (2009) 2.68

Identification of an adenylyl cyclase inhibitor for treating neuropathic and inflammatory pain. Sci Transl Med (2011) 2.67

Monitoring avian influenza A(H7N9) virus through national influenza-like illness surveillance, China. Emerg Infect Dis (2013) 2.61

Surveillance of demographic characteristics and health behaviors among adult cancer survivors--Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ (2012) 2.57

Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry (2004) 2.53

The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest (2009) 2.52

Hop is an unusual homeobox gene that modulates cardiac development. Cell (2002) 2.52

Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res (2003) 2.52

Molecular mimicry regulates ABA signaling by SnRK2 kinases and PP2C phosphatases. Science (2011) 2.52

Markers for detergent-resistant lipid rafts occupy distinct and dynamic domains in native membranes. Mol Biol Cell (2004) 2.50

Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology (2004) 2.48

Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci U S A (2003) 2.44

Labor progression and risk of cesarean delivery in electively induced nulliparas. Obstet Gynecol (2005) 2.44

Horizontal transfer of an adaptive chimeric photoreceptor from bryophytes to ferns. Proc Natl Acad Sci U S A (2014) 2.42

Electronic origin of high-temperature superconductivity in single-layer FeSe superconductor. Nat Commun (2012) 2.37

Basis set exchange: a community database for computational sciences. J Chem Inf Model (2007) 2.37

Phase diagram and electronic indication of high-temperature superconductivity at 65 K in single-layer FeSe films. Nat Mater (2013) 2.34

Inhibition of the catalytic function of activation-induced cytidine deaminase promotes apoptosis of germinal center B cells in BXD2 mice. Arthritis Rheum (2011) 2.33

Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J Clin Invest (2014) 2.31

The research implications of the selection of a gestational age estimation method. Paediatr Perinat Epidemiol (2007) 2.29

Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res (2002) 2.28

Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol Cell (2009) 2.27

The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens. Nat Immunol (2003) 2.26

West Nile virus. Lancet Neurol (2007) 2.26

Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev (2008) 2.22

Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol (2010) 2.20

The effect of lidocaine on early postoperative cognitive dysfunction after coronary artery bypass surgery. Anesth Analg (2002) 2.20

Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun (2005) 2.18

Mapping the murine cardiac 26S proteasome complexes. Circ Res (2006) 2.17

A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J (2006) 2.17

Sperm, but not oocyte, DNA methylome is inherited by zebrafish early embryos. Cell (2013) 2.16

Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol (2013) 2.16

Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J Biol Chem (2004) 2.16

Association between crystals and cartilage degeneration in the ankle. J Rheumatol (2008) 2.15